American Health Packaging recalled 1,062 cartons of Chlorpromazine Hydrochloride Tablets on August 27, 2025. The recall stems from the detection of a micro-organism in auxiliary packaging materials. No micro-organism was found on the tablets themselves, but consumers should stop using the product immediately.
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Consumers and healthcare providers should stop using this product immediately. Contact Amerisource Health Services LLC or your healthcare provider for guidance. Notification method: Letter
The recalled product is Chlorpromazine Hydrochloride Tablets, USP, 50 mg, distributed in 100 blister packs. It carries NDC# 60687-441-01. The affected lot numbers are 1022159, 1023299, and 1024057.
The recall involves the presence of a foreign substance detected in the product packaging. A specific lot of auxiliary polyester coil was found to have a micro-organism, posing potential health risks.
No injuries or illnesses have been reported related to this recall. The manufacturer detected no micro-organism on any of the tablets.
Consumers should stop using the recalled tablets immediately. Contact Amerisource Health Services LLC or consult your healthcare provider for further guidance.
For more information, visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0648-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.